Gentamicin Sulfate Ophthalmic Solution USP, 0.3% (Sterile)

Manufacturer
Medsource Pharmaceuticals
Effective date
2019-12-27
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:31:02

Label at a glance#

ProductGentamicin Sulfate
Active ingredientGENTAMICIN SULFATE
Label structure12 sections

Indications and uses

Gentamicin sulfate ophthalmic solution is indicated in the topical treatment of ocular bacterial infections including conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis, and dacryocystitis, caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneu...

Dosage and administration

Instill one or two drops into the affected eye(s) every four hours. In severe infections dosage may be increased to as much as two drops every hour.

Storage and handling

Storage: Store between 2°- 25°C (36°- 77°F). Avoid exposure to excessive heat. KEEP OUT OF REACH OF CHILDREN. Revised: January 2013 Bausch & Lomb Incorporated Tampa, FL 33637 ©Bausch & Lomb Incorporated 9116002 (Folded) 9116102 (Flat)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx only

DESCRIPTION

DESCRIPTION SECTION

Gentamicin Sulfate Ophthalmic Solution, is a sterile, aqueous solution buffered to approximately pH 7.0 and formulated for ophthalmic use.

EACH mL CONTAINS:

ACTIVE: Gentamicin Sulfate (equivalent to 3 mg gentamicin).

INACTIVES: Dibasic Sodium Phosphate, Sodium Chloride, Monobasic Sodium Phosphate, Purified Water. Hydrochloric Acid and/or Sodium Hydroxide may be added to adjust pH (6.5 - 7.5).

PRESERVATIVE ADDED: Benzalkonium Chloride 0.01%.

Gentamicin is an aminoglycoside antibiotic obtained from cultures of Micromonospora purpurea. It is a mixture of the sulfate salts of Gentamicin C 1, C 2, C 1a and C 2a. All three components appear to have similar antimicrobial activity.

Gentamicin sulfate occurs as a white to buff powder and is soluble in water and insoluble in alcohol.

The structural formula is as follows:

Gentamicin Sulfate (structural formula)
Gentamicin Sulfate (structural formula)

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Microbiology

Gentamicin sulfate is active in vitro against many strains of the following microorganisms:

Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes Escherichia coli; Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Gentamicin sulfate ophthalmic solution is indicated in the topical treatment of ocular bacterial infections including conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis, and dacryocystitis, caused by susceptible strains of the following microorganisms:

Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli; Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Gentamicin sulfate ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.

WARNINGS

WARNINGS SECTION

NOT FOR INJECTION INTO THE EYE.

Gentamicin sulfate ophthalmic solution is not for injection. It should never be injected subconjunctivally, nor should it be directly introduced into the anterior chamber of the eye.

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

Prolonged use of topical antibiotics may give rise to overgrowth of nonsusceptible organisms including fungi.

Bacterial resistance to gentamicin may also develop. If purulent discharge, inflammation or pain becomes aggravated, the patient should discontinue use of the medication and consult a physician. If irritation or hypersensitivity to any component of the drug develops, the patient should discontinue use of this preparation and appropriate therapy should be instituted.

Information for Patients:

INFORMATION FOR PATIENTS SECTION

To avoid contamination, do not touch tip of container to the eye, eyelid or any surface.

Carcinogenesis, Mutagenesis, Impairment of Fertility:

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

There are no published carcinogenicity or impairment of fertility studies on gentamicin. Aminoglycoside antibiotics have been found to be non-mutagenic.

Pregnancy:

PREGNANCY SECTION

Pregnancy Category C. Gentamicin has been shown to depress body weights, kidney weights and median glomerular counts in newborn rats when administered systemically to pregnant rats in daily doses approximately 500 times the maximum recommended ophthalmic human dose. There are no adequate and well-controlled studies in pregnant women. Gentamicin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Bacterial and fungal corneal ulcers have developed during treatment with gentamicin ophthalmic preparations.

The most frequently reported adverse reactions are ocular burning and irritation upon drug instillation, non-specific conjunctivitis, conjunctival epithelial defects and conjunctival hyperemia.

Other adverse reactions which have occurred rarely are allergic reactions, thrombocytopenic purpura and hallucinations.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Instill one or two drops into the affected eye(s) every four hours. In severe infections dosage may be increased to as much as two drops every hour.

HOW SUPPLIED

HOW SUPPLIED SECTION

Gentamicin Sulfate Ophthalmic Solution USP, 0.3% is supplied in a plastic bottle with a controlled drop tip in the following sizes:

5 mL - NDC 24208-580-60

15 mL - NDC 24208-580-64


NOT FOR INJECTION

FOR OPHTHALMIC USE ONLY

DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT.

STORAGE AND HANDLING SECTION

Storage: Store between 2°- 25°C (36°- 77°F). Avoid exposure to excessive heat.

KEEP OUT OF REACH OF CHILDREN.

Revised: January 2013

Bausch & Lomb Incorporated
Tampa, FL 33637
©Bausch & Lomb Incorporated

9116002 (Folded)
9116102 (Flat)

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

pdppdp

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
310467gentamicin sulfate 0.3 % Ophthalmic SolutionPSN2
310467gentamicin 3 MG/ML Ophthalmic SolutionSCD2
310467gentamicin (as gentamicin sulfate) 0.3 % Ophthalmic SolutionSY2
310467gentamicin sulfate 3 MG/ML Ophthalmic SolutionSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GENTAMICIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3b7b3a7a-635f-32a3-0c6c-7ad028e3de91Product name220250107
43025f0d-698c-68da-cec9-ea4261a7ef7aProduct name220250107
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
d3946667-8212-d1f2-67e1-5643a329bb56Product name220200403
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
4ce5dce5-e8a7-e4f6-0059-b527e4307477Product name220190501
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
48b05f5d-d2fc-45ab-76e8-3cb5bd44890dProduct name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
45865-672-012025-01-30C16284748780-12cef2736-a459-d83d-e063-dadaa90ab31fGentamicin Sulfate Ophthalmic Solution USP, 0.3% (Sterile)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
45865-672-01Gentamicin Sulfate1 in 1 CARTONSOLUTION/ DROPS12
45865-672-01Gentamicin Sulfate5 mL in 1 BOTTLE, DROPPERSOLUTION/ DROPS52

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
45865-672GENTAMICIN SULFATE SOLUTION/ DROPS [MEDSOURCE PHARMACEUTICALS]2Legacy NDC, 2 package rows20191228_1f908b73-d829-4c6f-e054-00144ff8d46c.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
24208-580-60ML - Milliliter24208-580462515c7-1366-46c5-87db-5b20a94dd6c912012-07-24
24208-580-64ML - Milliliter24208-580d1064568-058d-41df-b518-a1284803ebfc12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
GENTAMICIN SULFATEACTIVE INGREDIENT8X7386QRLV1
GENTAMICINACTIVE MOIETYT6Z9V48IKG1
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W71
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CB1
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8X1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I1
SODIUM PHOSPHATE, DIBASICINACTIVE INGREDIENTGR686LBA741
SODIUM PHOSPHATE, MONOBASICINACTIVE INGREDIENT3980JIH2SW1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
45865-67245865-672-01
24208-580

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 14 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM PHOSPHATE, MONOBASICSODIUM PHOSPHATE, MONOBASIC3980JIH2SWTABLET / ORAL2 mgExact identifier — unii candidate
9 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASICSODIUM PHOSPHATE, MONOBASIC3980JIH2SWINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS0.22 mgExact identifier — unii candidate
9 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASICSODIUM PHOSPHATE, MONOBASIC3980JIH2SWSOLUTION / ORAL25 mg/5mlExact identifier — unii candidate
9 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASICSODIUM PHOSPHATE, DIBASICGR686LBA74SUSPENSION / OPHTHALMIC0.43 %w/wExact identifier — unii+route
SODIUM PHOSPHATE, MONOBASICSODIUM PHOSPHATE, MONOBASIC3980JIH2SWINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS13.2 mgExact identifier — unii candidate
9 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASICSODIUM PHOSPHATE, MONOBASIC3980JIH2SWINJECTION / INTRAMUSCULAR161 mgExact identifier — unii candidate
9 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
SODIUM PHOSPHATE, MONOBASICSODIUM PHOSPHATE, MONOBASIC3980JIH2SWINJECTION / INTRAVENOUS161 mgExact identifier — unii candidate
9 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASICSODIUM PHOSPHATE, MONOBASIC3980JIH2SWINJECTION, SUSPENSION / SUBCUTANEOUS0.07 %w/vExact identifier — unii candidate
9 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii+route+dosage form
SODIUM PHOSPHATE, MONOBASICSODIUM PHOSPHATE, MONOBASIC3980JIH2SWSYSTEM / IONTOPHORESIS14.2 mgExact identifier — unii candidate
9 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASICSODIUM PHOSPHATE, MONOBASIC3980JIH2SWSYSTEM / TOPICAL14.2 mgExact identifier — unii candidate
9 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / OPHTHALMIC55 mgExact identifier — unii+route+dosage form

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A064048-001GENTAMICIN SULFATEGENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A064048-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-1184e616aacf4f…
2026-08-18 06:07:402026-07A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-111e350fbaab3a…
2024-05-31 18:47 UTC2024-05A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-118072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-115c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-115d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-114b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-1174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-1187673890dc5c…
2021-03-12 10:30 UTC2021-03A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-115aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-118869cabd3fbd…
2020-11-12 02:37 UTC2020-11A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11c0c555d07b60…
2019-12-14 00:12 UTC2019-12A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-113f01610625f2…
2019-09-15 20:21 UTC2019-09A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11b00525d2431f…
2019-07-19 19:46 UTC2019-07A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-116a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-111c564ffb4f44…
2023-12-20 04:57 UTC2023-12A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-119b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-113f0d92c62455…
2023-05-13 08:27 UTC2023-05A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11053a50430f4f…
2023-01-26 05:58 UTC2023-01A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-113bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-113a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A064048-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICAT1994-05-11f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A064048-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A064048-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A064048-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A064048-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A064048-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A064048-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A064048-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A064048-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A064048-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A064048-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A064048-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A064048-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A064048-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A064048-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A064048-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A064048-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A064048-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A064048-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A064048-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A064048-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A064048-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A064048-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A064048-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A064048-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A064048-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A064048-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A064048-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A064048-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A064048-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A064048-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A064048-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A064048-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A064048-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A064048-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A064048-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A064048-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A064048-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A064048-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A064048-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A064048-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Gentamicin SulfateGENTAMICIN SULFATEBausch & Lomb Incorporated41d01350-5c4b-42fc-be5f-986ceec02bd32024-07-22Warnings, Adverse reactionsExact identifier
ndc (product): 24208-580
9ab3823b-9674-f077-e053-2995a90a740b1f908b73-d829-4c6f-e054-00144ff8d46c2019-12-27Warnings, Adverse reactionsExact identifier
spl id: 9ab3823b-9674-f077-e053-2995a90a740b
spl set id: 1f908b73-d829-4c6f-e054-00144ff8d46c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.